These findings suggest that our amyloid-β and tau networks reflected the accumulation of pathological changes occurring in postmortem studies in patients at early and advanced stages of Alzheimer’s disease. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.